No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
| Rizwan Ahmad | CEO |
| Nadeem Amjad | Chairperson |
| Ghulam Dastgeer | Company Secretary |
F.D Registrar Services (Pvt.) Ltd.
Aslam Malik & Co. Chartered Accountants
June
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Oct 30, 2025 | TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED | View PDF |
| Oct 29, 2025 | Financial Results for the Quarter Ended | View PDF |
| Oct 7, 2025 | Transmission of Annual Report for the Year Ended | View PDF |
| Oct 2, 2025 | Financial Results for the year ended | View PDF |
| May 2, 2025 | Transmission of financial statements for the Nine Months period ended 31 March 2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Nov 13, 2025 | Certified True Copy of the Resolutions Passed in the Annual General Meeting | View PDF |
| Oct 29, 2025 | Board Meeting Other Than Financial Results (Post Election BOD Meeting) | View |
| Oct 24, 2025 | Board Meeting | View |
| Oct 6, 2025 | Notice of Annual General Meeting | View PDF |
| Sep 25, 2025 | Board Meeting | View |
| Date | Title | Document |
|---|---|---|
| Nov 6, 2025 | Credit of Final Cash Dividend (2025) | View PDF |
| Oct 20, 2025 | Notice of Election of Directors u/s 159(4) of the Companies Act, 2017 | View PDF |
| Oct 16, 2025 | CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS | View PDF |
| Sep 12, 2025 | Material Information | View PDF |
| Aug 6, 2025 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View |
Financials
All numbers in thousands (000's) except EPS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 13,153,521 | 12,409,239 | 12,396,983 | 9,779,880 |
| Profit after Taxation | 892,039 | 833,464 | 657,984 | 635,884 |
| EPS | 3.90 | 3.65 | 2.88 | 2.88 |
| Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|
| Sales | 3,370,247 | 3,341,108 | 3,534,432 | 3,224,645 |
| Profit after Taxation | 203,691 | 220,375 | 256,979 | 201,497 |
| EPS | 0.89 | 0.96 | 1.12 | 0.88 |

Ratios
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 15.34 | 12.78 | 12.16 | 13.83 |
| Net Profit Margin (%) | 6.78 | 6.72 | 5.31 | 6.50 |
| EPS Growth (%) | 6.85 | 26.74 | (20.88) | |
| PEG | 3.14 | 0.29 | (0.54) |
Payouts
| Date | Financial Results | Details | Book Closure |
|---|---|---|---|
| October 2, 2025 4:35 PM | 30/06/2025(YR) | 35%(F) (D) | 21/10/2025 - 27/10/2025 |
| October 2, 2024 2:52 PM | 30/06/2024(YR) | 32.50%(F) (D) | 21/10/2024 - 28/10/2024 |
| September 28, 2023 4:07 PM | 30/06/2023(YR) | 25%(F) (D) | 20/10/2023 - 27/10/2023 |
| September 30, 2021 9:32 PM | 30/06/2021(YR) | 15% (D) - 10% (B) | 21/10/2021 - 28/10/2021 |









Feedback
Terms of Use
https://www.psx.com.pk